Home » Health » the Haute Autorité de santé recommends a booster dose from the age of 40

the Haute Autorité de santé recommends a booster dose from the age of 40

Afsané Sabouhi, edited by Gauthier Delomez with AFP
, modified at

7:13 p.m., November 19, 2021

While the Covid-19 epidemic is experiencing a new rebound in metropolitan France, health authorities recommend expanding the scope of populations eligible for a vaccine booster dose to those 40 and over, according to a press release Friday.

While the Covid-19 epidemic is experiencing a new rebound in metropolitan France, health authorities recommend expanding the scope of populations eligible for a vaccine booster dose to those 40 and over, according to a press release Friday. The High Authority for Health (HAS) recommends doing this booster six months after the primary vaccination, “the latest studies indeed suggest a benefit for this age group”. Its advice is generally followed by the government.

Reminders for all vaccinated, “the sense of history” for Macron

The effectiveness of vaccines against symptomatic infections declines over time, which partly explains the epidemic rebound in France and Europe. So far, the recall only concerned people over 65 and people at serious risk. From December 15, it will be required to extend their health pass.

President Emmanuel Macron announced in early November that the recall would be available to 50-64 year olds from December 1. And shortly before the publication of the opinion of the HAS on Friday, he sold the wick on the enlargement: “I would not be surprised that we are gradually moving towards vaccine boosts for all adults who have been vaccinated, it is the meaning of history, “he said during a trip to the North.

The systematic recall for all, decided by Germany and probably soon the United States, however, does not achieve consensus among all scientists. Some argue that two doses are still very effective against severe forms of illness and death, and that the urgent need is to vaccinate those who have not had any doses. In France, this concerns some 6 million people among the eligible population (over 12 years old).

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.